• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

对存在于SV40转化细胞和未感染胚胎癌细胞中的一种54K道尔顿细胞SV40肿瘤抗原的特性分析。

Characterization of a 54K dalton cellular SV40 tumor antigen present in SV40-transformed cells and uninfected embryonal carcinoma cells.

作者信息

Linzer D I, Levine A J

出版信息

Cell. 1979 May;17(1):43-52. doi: 10.1016/0092-8674(79)90293-9.

DOI:10.1016/0092-8674(79)90293-9
PMID:222475
Abstract

SV40 infection or transformation of murine cells stimulated the production of a 54K dalton protein that was specifically immunoprecipitated, along with SV40 large T and small t antigens, with sera from mice or hamsters bearing SV40-induced tumors. The same SV40 anti-T sera immunoprecipitated a 54K dalton protein from two different, uninfected murine embryonal carcinoma cell lines. These 54K proteins from SV40-transformed mouse cells and the uninfected embryonal carcinomas cells had identical partial peptide maps which were completely different from the partial peptide map of SV40 large T antigen. An Ad2+ND4-transformed hamster cell line also expressed a 54K protein that was specifically immunoprecipitated by SV40 T sera. The partial peptide maps of the mouse and hamster 54K protein were different, showing the host cell species specificity of these proteins. The 54K hamster protein was also unrelated to the Ad2+ND4 SV40 T antigen. Analogous proteins immunoprecipitated by SV40 T sera, ranging in molecular weight from 44K to 60K, were detected in human and monkey SV40-infected or -transformed cells. A wide variety of sera from hamsters and mice bearing SV40-induced tumors immunoprecipitated the 54K protein of SV40-transformed cells and murine embryonal carcinoma cells. Antibody produced by somatic cell hybrids between a B cell and a myeloma cell (hybridoma) against SV40 large T antigen also immunoprecipitated the 54K protein in virus-infected and -transformed cells, but did not do so in the embryonal carcinoma cell lines. We conclude that SV40 infection or transformation of mouse cells stimulates the synthesis or enhances the stability of a 54K protein. This protein appears to be associated with SV40 T antigen in SV40-infected and -transformed cells, and is co-immunoprecipitated by hybridomas sera to SV40 large T antigen. The 54K protein either shares antigenic determinants with SV40 T antigen or is itself immunogenic when in association with SV40 large T antigen. The protein varies with host cell species, and analogous proteins were observed in hamster, monkey and human cells. The role of this protein in transformation is unclear at present.

摘要

SV40对鼠细胞的感染或转化刺激产生了一种54K道尔顿的蛋白质,该蛋白质与SV40大T抗原和小t抗原一起,被携带SV40诱导肿瘤的小鼠或仓鼠血清特异性免疫沉淀。相同的SV40抗T血清从两种不同的未感染鼠胚胎癌细胞系中免疫沉淀出一种54K道尔顿的蛋白质。来自SV40转化的小鼠细胞和未感染的胚胎癌细胞的这些54K蛋白质具有相同的部分肽图谱,这与SV40大T抗原的部分肽图谱完全不同。一种Ad2+ND4转化的仓鼠细胞系也表达一种54K蛋白质,该蛋白质被SV40 T血清特异性免疫沉淀。小鼠和仓鼠54K蛋白质的部分肽图谱不同,显示出这些蛋白质的宿主细胞物种特异性。仓鼠的54K蛋白质也与Ad2+ND4 SV40 T抗原无关。在人类和猴的SV40感染或转化细胞中检测到了被SV40 T血清免疫沉淀的类似蛋白质,其分子量在44K到60K之间。多种来自携带SV40诱导肿瘤的仓鼠和小鼠的血清免疫沉淀了SV40转化细胞和鼠胚胎癌细胞的54K蛋白质。由B细胞和骨髓瘤细胞(杂交瘤)之间的体细胞杂交产生的针对SV40大T抗原的抗体也免疫沉淀了病毒感染和转化细胞中的54K蛋白质,但在胚胎癌细胞系中未出现这种情况。我们得出结论,SV40对小鼠细胞的感染或转化刺激了一种54K蛋白质的合成或增强了其稳定性。这种蛋白质在SV40感染和转化的细胞中似乎与SV40 T抗原相关,并被针对SV40大T抗原的杂交瘤血清共免疫沉淀。54K蛋白质要么与SV40 T抗原共享抗原决定簇,要么在与SV40大T抗原结合时本身具有免疫原性。该蛋白质因宿主细胞物种而异,并且在仓鼠、猴和人类细胞中观察到了类似的蛋白质。目前尚不清楚这种蛋白质在转化中的作用。

相似文献

1
Characterization of a 54K dalton cellular SV40 tumor antigen present in SV40-transformed cells and uninfected embryonal carcinoma cells.对存在于SV40转化细胞和未感染胚胎癌细胞中的一种54K道尔顿细胞SV40肿瘤抗原的特性分析。
Cell. 1979 May;17(1):43-52. doi: 10.1016/0092-8674(79)90293-9.
2
Antigenic and immunogenic characteristics of nuclear and membrane-associated simian virus 40 tumor antigen.核及膜相关猿猴病毒40肿瘤抗原的抗原性和免疫原性特征
J Virol. 1980 Feb;33(2):887-901. doi: 10.1128/JVI.33.2.887-901.1980.
3
Characterization of a murine cellular SV40 T antigen in SV40-transformed cells and uninfected embryonal carcinoma cells.SV40转化细胞和未感染胚胎癌细胞中鼠源细胞型SV40 T抗原的特性分析。
Cold Spring Harb Symp Quant Biol. 1980;44 Pt 1,:215-24. doi: 10.1101/sqb.1980.044.01.025.
4
Simian virus 40 T- and U-antigens: immunological characterization and localization in different nuclear subfractions of simian virus 40-transformed cells.猴病毒40 T抗原和U抗原:免疫特性及在猴病毒40转化细胞不同核亚组分中的定位
J Virol. 1979 Feb;29(2):576-86. doi: 10.1128/JVI.29.2.576-586.1979.
5
Antiserum to SV40 T antigens from a rabbit inoculated with autochthonous cells transformed in vitro by SV40.来自接种了经SV40体外转化的本地细胞的兔子的抗SV40 T抗原抗血清。
Gan. 1981 Oct;72(5):769-71.
6
Characterization of the surface proteins of SV40-transformed mouse and human cells: absence of SV40-specific proteins.SV40转化的小鼠和人类细胞表面蛋白的特性:缺乏SV40特异性蛋白。
Int J Cancer. 1983 May 15;31(5):639-48. doi: 10.1002/ijc.2910310517.
7
The expression of SV40 large T-antigen in embryonal carcinoma--SV40 transformed somatic cell hybrids.猿猴病毒40大T抗原在胚胎癌——猿猴病毒40转化的体细胞杂种中的表达。
Virology. 1980 Jan 30;100(2):492-4. doi: 10.1016/0042-6822(80)90540-1.
8
Monoclonal antibodies against simian virus 40 T antigens: evidence for distinct sublcasses of large T antigen and for similarities among nonviral T antigens.抗猴病毒40 T抗原的单克隆抗体:大T抗原不同亚类的证据以及非病毒T抗原间相似性的证据
J Virol. 1980 Jun;34(3):752-63. doi: 10.1128/JVI.34.3.752-763.1980.
9
Detection of simian virus 40 T-antigen-related antigens by a 125I-protein A-binding assay and by immunofluorescence microscopy on the surface of SV40-transformed monolayer cells.通过125I-蛋白A结合测定法以及免疫荧光显微镜术在猴病毒40(SV40)转化的单层细胞表面检测与SV40 T抗原相关的抗原。
J Gen Virol. 1981 Feb;52(Pt 2):301-12. doi: 10.1099/0022-1317-52-2-301.
10
Evidence for simian virus 40 (SV40) coding of SV40 T-antigen and the SV40-specific proteins in HeLa cells infected with nondefective adenovirus type 2-SV40 hybrid viruses.在感染无缺陷腺病毒2型-猿猴病毒40(SV40)杂交病毒的HeLa细胞中,关于SV40 T抗原和SV40特异性蛋白由SV40编码的证据。
J Virol. 1977 Oct;24(1):151-69. doi: 10.1128/JVI.24.1.151-169.1977.

引用本文的文献

1
Dissecting cross-lineage tumourigenesis under p53 inactivation through single-cell multi-omics and spatial transcriptomics.通过单细胞多组学和空间转录组学剖析p53失活状态下的跨谱系肿瘤发生
Clin Transl Med. 2025 Sep;15(9):e70461. doi: 10.1002/ctm2.70461.
2
Evaluation of human papillomavirus as a risk factor in prostate cancer pathogenesis.评估人乳头瘤病毒作为前列腺癌发病机制中的一个风险因素。
Discov Oncol. 2025 Jul 19;16(1):1375. doi: 10.1007/s12672-025-03236-1.
3
Discovery of Drugs Targeting Mutant p53 and Progress in Nano-Enabled Therapeutic Strategy for p53-Mutated Cancers.
靶向突变型p53的药物发现及p53突变型癌症的纳米治疗策略进展
Biomolecules. 2025 May 26;15(6):763. doi: 10.3390/biom15060763.
4
Germline TP53 p.R337H and XAF1 p.E134* Variants: Prevalence in Paraguay and Comparison with Rates in Brazilian State of Paraná and Previous Findings at the Paraguayan-Brazilian Border.种系TP53 p.R337H和XAF1 p.E134*变异:巴拉圭的患病率及其与巴西巴拉那州患病率的比较以及巴拉圭-巴西边境地区既往研究结果对比
Curr Oncol. 2025 Jun 6;32(6):333. doi: 10.3390/curroncol32060333.
5
Viral oncogenesis in cancer: from mechanisms to therapeutics.癌症中的病毒致癌作用:从机制到治疗
Signal Transduct Target Ther. 2025 May 12;10(1):151. doi: 10.1038/s41392-025-02197-9.
6
Latest News from the "Guardian": p53 Directly Activates Asymmetric Stem Cell Division Regulators.《卫报》最新消息:p53直接激活不对称干细胞分裂调节因子。
Int J Mol Sci. 2025 Mar 29;26(7):3171. doi: 10.3390/ijms26073171.
7
Recent progress and future challenges in structure-based protein-protein interaction prediction.基于结构的蛋白质-蛋白质相互作用预测的最新进展与未来挑战
Mol Ther. 2025 May 7;33(5):2252-2268. doi: 10.1016/j.ymthe.2025.04.003. Epub 2025 Apr 6.
8
Harnessing p53 for targeted cancer therapy: new advances and future directions.利用p53进行靶向癌症治疗:新进展与未来方向。
Transcription. 2025 Feb;16(1):3-46. doi: 10.1080/21541264.2025.2452711. Epub 2025 Mar 3.
9
Interactions between key genes and pathways in prostate cancer progression and therapy resistance.前列腺癌进展和治疗抵抗中关键基因与信号通路之间的相互作用。
Front Oncol. 2025 Jan 23;15:1467540. doi: 10.3389/fonc.2025.1467540. eCollection 2025.
10
Effects of Tp53 Gene Mutations on the Survival of Non-Small Cell Lung Cancer (NSCLC); A Short Review.Tp53基因突变对非小细胞肺癌(NSCLC)生存的影响;简短综述。
Cancer Manag Res. 2025 Jan 15;17:65-82. doi: 10.2147/CMAR.S495006. eCollection 2025.